1.
Bol. méd. Hosp. Infant. Méx
;
47(5): 293-4, mayo 1990.
Article
in Spanish
| LILACS
| ID: lil-99094
Subject(s)
Pertussis Vaccine/adverse effects , Pertussis Vaccine/therapeutic use , Pertussis Vaccine/toxicity , Diphtheria Toxoid/adverse effects , Diphtheria Toxoid/toxicity , Diphtheria Toxoid/therapeutic use , Tetanus Toxoid/adverse effects , Tetanus Toxoid/toxicity , Tetanus Toxoid/therapeutic use
2.
Indian J Exp Biol
;
1990 Mar; 28(3): 218-20
Article
in English
| IMSEAR
| ID: sea-57971
ABSTRACT
Since the naturally acquired tetanus antitoxin titre in Indian population is mostly less than protective levels, to minimise the incidence of morbidity, Glaxo Laboratories (India) Ltd., Bombay have prepared a single dose potent tetanus vaccine of 250 Lf as compared to 5 Lf previous tetanus toxoid. Subacute toxicity study revealed that this toxoid (250 Lf) injected at different dose levels (1-2 ml/rat/injection x 4) is non-toxic to rats.